Noren E, Blomberg A, Lindh C, Pineda D, Jakobsson K, Nielsen C
J Expo Sci Environ Epidemiol. 2025; .
PMID: 40050414
DOI: 10.1038/s41370-025-00758-2.
Yuan K, Xiong J, Yuan B
Se Pu. 2024; 43(1):13-21.
PMID: 39722617
PMC: 11686480.
DOI: 10.3724/SP.J.1123.2024.07002.
Li Z, Wang G, Braun J, Hong X, Choi G, OLeary S
Environ Int. 2024; 195:109206.
PMID: 39705976
PMC: 11786237.
DOI: 10.1016/j.envint.2024.109206.
Tian C, Cai H, Ao Z, Gu L, Li X, Niu V
Sci Total Environ. 2024; 947:174478.
PMID: 38964381
PMC: 11404128.
DOI: 10.1016/j.scitotenv.2024.174478.
Azab S, Hum R, Britz-McKibbin P
Anal Sci Adv. 2024; 1(3):173-182.
PMID: 38716130
PMC: 10989087.
DOI: 10.1002/ansa.202000053.
There's Something in What We Eat: An Overview on the Extraction Techniques and Chromatographic Analysis for PFAS Identification in Agri-Food Products.
Iannone A, Carriera F, Passarella S, Fratianni A, Avino P
Foods. 2024; 13(7).
PMID: 38611389
PMC: 11011820.
DOI: 10.3390/foods13071085.
Prenatal Exposure to Perfluoroalkyl Substances and Child Behavior at Age 12: A PELAGIE Mother-Child Cohort Study.
Tillaut H, Monfort C, Rouget F, Pele F, Laine F, Gaudreau E
Environ Health Perspect. 2023; 131(11):117009.
PMID: 37971539
PMC: 10653211.
DOI: 10.1289/EHP12540.
Exposure to perfluoroalkyl and polyfluoroalkyl substances and pediatric obesity: a systematic review and meta-analysis.
Frangione B, Birk S, Benzouak T, Rodriguez-Villamizar L, Karim F, Dugandzic R
Int J Obes (Lond). 2023; 48(2):131-146.
PMID: 37907715
PMC: 10824662.
DOI: 10.1038/s41366-023-01401-6.
Fluorine Mass Balance, including Total Fluorine, Extractable Organic Fluorine, Oxidizable Precursors, and Target Per- and Polyfluoroalkyl Substances, in Pooled Human Serum from the Tromsø Population in 1986, 2007, and 2015.
Cioni L, Plassmann M, Benskin J, Carolina M F Coelho A, Nost T, Rylander C
Environ Sci Technol. 2023; 57(40):14849-14860.
PMID: 37747946
PMC: 10569050.
DOI: 10.1021/acs.est.3c03655.
Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study.
Vollmar A, Lin E, Nason S, Santiago K, Johnson C, Ma X
J Expo Sci Environ Epidemiol. 2023; 33(5):737-747.
PMID: 37730931
PMC: 10541328.
DOI: 10.1038/s41370-023-00603-4.
Newborn metabolomic signatures of maternal per- and polyfluoroalkyl substance exposure and reduced length of gestation.
Taibl K, Dunlop A, Barr D, Li Y, Eick S, Kannan K
Nat Commun. 2023; 14(1):3120.
PMID: 37253729
PMC: 10229585.
DOI: 10.1038/s41467-023-38710-3.
Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort.
Goodman C, Till C, Green R, El-Sabbagh J, Arbuckle T, Hornung R
Neurotoxicol Teratol. 2023; 98:107181.
PMID: 37178772
PMC: 10979774.
DOI: 10.1016/j.ntt.2023.107181.
Determinants of maternal and neonatal PFAS concentrations: a review.
McAdam J, Bell E
Environ Health. 2023; 22(1):41.
PMID: 37161484
PMC: 10170754.
DOI: 10.1186/s12940-023-00992-x.
Evaluation of Per- and Polyfluoroalkyl Substances (PFAS) Toxicity Testing for Developmental Neurotoxicity.
Carstens K, Freudenrich T, Wallace K, Choo S, Carpenter A, Smeltz M
Chem Res Toxicol. 2023; 36(3):402-419.
PMID: 36821828
PMC: 10249374.
DOI: 10.1021/acs.chemrestox.2c00344.
The Association between Prenatal Per- and Polyfluoroalkyl Substances Exposure and Neurobehavioral Problems in Offspring: A Meta-Analysis.
Yao H, Fu Y, Weng X, Zeng Z, Tan Y, Wu X
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767045
PMC: 9914055.
DOI: 10.3390/ijerph20031668.
Cross-sectional associations of maternal PFAS exposure on SARS-CoV-2 IgG antibody levels during pregnancy.
Kaur K, Lesseur C, Chen L, Andra S, Narasimhan S, Pulivarthi D
Environ Res. 2022; 219:115067.
PMID: 36528042
PMC: 9747685.
DOI: 10.1016/j.envres.2022.115067.
A High-Throughput Toxicity Screen of 42 Per- and Polyfluoroalkyl Substances (PFAS) and Functional Assessment of Migration and Gene Expression in Human Placental Trophoblast Cells.
Blake B, Rickard B, Fenton S
Front Toxicol. 2022; 4:881347.
PMID: 35548680
PMC: 9081605.
DOI: 10.3389/ftox.2022.881347.
Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Child Growth Trajectories in the First Two Years.
Gao Y, Luo J, Zhang Y, Pan C, Ren Y, Zhang J
Environ Health Perspect. 2022; 130(3):37006.
PMID: 35285689
PMC: 8919954.
DOI: 10.1289/EHP9875.
Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise L, Wesselink A, Schildroth S, Calafat A, Bethea T, Geller R
Environ Res. 2021; 203:111860.
PMID: 34403666
PMC: 8616815.
DOI: 10.1016/j.envres.2021.111860.
Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast.
Pham A, Zhang J, Feng L
Reprod Toxicol. 2020; 98:269-277.
PMID: 33144174
PMC: 9387162.
DOI: 10.1016/j.reprotox.2020.10.013.